NASDAQ: ATXS
Astria Therapeutics Inc Stock Ownership - Who owns Astria Therapeutics?

Insider buying vs selling

Have Astria Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ATXS insiders and whales buy or sell their stock.

ATXS Shareholders

What type of owners hold Astria Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.86%7,823,729$40.06MInstitution
Perceptive Advisors LLC11.49%6,485,420$33.21MInstitution
Ra Capital Management LP9.05%5,105,213$26.14MInstitution
Vestal Point Capital LP7.41%4,180,000$21.40MInstitution
Blackrock Inc6.91%3,896,865$19.95MInstitution
Fairmount Funds Management LLC6.30%3,554,129$18.20MInstitution
Fcpm III Services Bv5.09%2,872,537$14.71MInstitution
Tcg Crossover Management LLC4.89%2,761,861$14.14MInstitution
Clarus Lifesciences II LP4.88%2,752,488$14.09MInsider
Nicholas Galakatos4.88%2,752,488$14.09MInsider

1 of 3

ATXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATXS80.96%19.04%
AURA78.55%18.33%Net SellingNet Selling
TERN80.94%19.06%Net BuyingNet Selling
XOMA18.57%81.43%Net SellingNet Buying
ATAI7.33%36.99%Net BuyingNet Buying

Astria Therapeutics Stock Ownership FAQ

Who owns Astria Therapeutics?

Astria Therapeutics (NASDAQ: ATXS) is owned by 103.80% institutional shareholders, 24.41% Astria Therapeutics insiders, and 0.00% retail investors. Clarus Lifesciences II LP is the largest individual Astria Therapeutics shareholder, owning 2.75M shares representing 4.88% of the company. Clarus Lifesciences II LP's Astria Therapeutics shares are currently valued at $14.20M.

If you're new to stock investing, here's how to buy Astria Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.